234 related articles for article (PubMed ID: 16362392)
1. Successful steroid-sparing treatment of renal limited sarcoidosis with mycophenolate mofetil.
Moudgil A; Przygodzki RM; Kher KK
Pediatr Nephrol; 2006 Feb; 21(2):281-5. PubMed ID: 16362392
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil as a steroid-sparing agent in sarcoid-associated renal disease.
Zaidi AA; DeVita MV; Michelis MF; Rosenstock JL
Clin Nephrol; 2015 Jan; 83(1):41-4. PubMed ID: 24075023
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil as an alternative treatment in sarcoidosis.
Papiris S; Stagaki E; Papadaki G; Kolilekas L; Korbila I; Apollonatou V; Kallieri M; Gialafos H; Chatziioannou S; Papaioannou AI; Manali ED
Pulm Pharmacol Ther; 2019 Oct; 58():101840. PubMed ID: 31518648
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis.
Kouba DJ; Mimouni D; Rencic A; Nousari HC
Br J Dermatol; 2003 Jan; 148(1):147-8. PubMed ID: 12534610
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy.
Androdias G; Maillet D; Marignier R; Pinède L; Confavreux C; Broussolle C; Vukusic S; Sève P
Neurology; 2011 Mar; 76(13):1168-72. PubMed ID: 21444902
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic granulomatous interstitial nephritis responsive to mycophenolate mofetil therapy.
Leeaphorn N; Stokes MB; Ungprasert P; Lecates W
Am J Kidney Dis; 2014 Apr; 63(4):696-9. PubMed ID: 24315767
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
[TBL] [Abstract][Full Text] [Related]
8. Sarcoidal anemia and leukopenia treated with methotrexate and mycophenolate mofetil.
Kalajian AH; Van Meter JR; Callen JP
Arch Dermatol; 2009 Aug; 145(8):905-9. PubMed ID: 19687421
[TBL] [Abstract][Full Text] [Related]
9. Anti-glomerular basement membrane disease treated with mycophenolate mofetil, corticosteroids, and plasmapheresis.
Mori M; Nwaogwugwu U; Akers GR; McGill RL
Clin Nephrol; 2013 Jul; 80(1):67-71. PubMed ID: 23803597
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome.
Novak I; Frank R; Vento S; Vergara M; Gauthier B; Trachtman H
Pediatr Nephrol; 2005 Sep; 20(9):1265-8. PubMed ID: 15942779
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of mycophenolate mofetil in C3 glomerulonephritis.
Rabasco C; Cavero T; Román E; Rojas-Rivera J; Olea T; Espinosa M; Cabello V; Fernández-Juarez G; González F; Ávila A; Baltar JM; Díaz M; Alegre R; Elías S; Antón M; Frutos MA; Pobes A; Blasco M; Martín F; Bernis C; Macías M; Barroso S; de Lorenzo A; Ariceta G; López-Mendoza M; Rivas B; López-Revuelta K; Campistol JM; Mendizábal S; de Córdoba SR; Praga M;
Kidney Int; 2015 Nov; 88(5):1153-60. PubMed ID: 26221755
[TBL] [Abstract][Full Text] [Related]
13. Mizoribine for renal sarcoidosis: effective steroid tapering and prevention of recurrence.
Ito S; Harada T; Nakamura T; Imagawa T; Nagahama K; Sasaki T; Fujinaga S; Aihara Y; Yokota S
Pediatr Nephrol; 2009 Feb; 24(2):411-4. PubMed ID: 18791743
[TBL] [Abstract][Full Text] [Related]
14. The first case of sarcoidosis treated with mycophenolate mofetil.
Altschuler EL
Br J Dermatol; 2003 Aug; 149(2):442; discussion 442-3. PubMed ID: 12932272
[No Abstract] [Full Text] [Related]
15. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
Ginzler EM; Dooley MA; Aranow C; Kim MY; Buyon J; Merrill JT; Petri M; Gilkeson GS; Wallace DJ; Weisman MH; Appel GB
N Engl J Med; 2005 Nov; 353(21):2219-28. PubMed ID: 16306519
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of steroid-dependent minimal change-nephrotic syndrome with mycophenolate mofetil].
Noroña B; Valentín M; Gutiérrez E; Praga M
Nefrologia; 2004; 24(1):79-82. PubMed ID: 15083963
[TBL] [Abstract][Full Text] [Related]
17. [Neurosarcoidosis treated with mycophenolate mofetil: two cases].
Chaussenot A; Bourg V; Chanalet S; Fornari JM; Lebrun C
Rev Neurol (Paris); 2007 Apr; 163(4):471-5. PubMed ID: 17452949
[TBL] [Abstract][Full Text] [Related]
18. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
[TBL] [Abstract][Full Text] [Related]
19. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
